100 related articles for article (PubMed ID: 30218743)
1. The effects of cardiovascular risk factor combined anti-platelet therapy and the risk of cerebrovascular events in patients with T2DM in an urban community over 96-months follow-up: The Beijing communities diabetes study 19.
Zhang XL; Fu HJ; Yang GR; Wan G; Li D; Zhu LX; Xie RR; Lv YJ; Zhang JD; Li YL; Dai QF; Ji Y; Gao DY; Cui XL; Liu DY; Yuan SY; Yuan MX;
Diabetes Res Clin Pract; 2018 Oct; 144():236-244. PubMed ID: 30218743
[TBL] [Abstract][Full Text] [Related]
2. The effects of acarbose therapy on reductions of myocardial infarction and all-cause death in T2DM during 10-year multifactorial interventions (The Beijing Community Diabetes Study 24).
Zhang XL; Yuan SY; Wan G; Yuan MX; Yang GR; Fu HJ; Zhu LX; Zhang JD; Li YL; Gao DY; Cui XL; Wang ZM; Xie RR; Chen YJ
Sci Rep; 2021 Mar; 11(1):4839. PubMed ID: 33649485
[TBL] [Abstract][Full Text] [Related]
3. Improved Framingham Risk Scores of Patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year Prospective Study of the Effects of Multifactorial Interventions on Cardiovascular Risk Factors (The Beijing Communities Diabetes Study 22).
Zhang XL; Wan G; Yuan MX; Yang GR; Fu HJ; Zhu LX; Xie RR; Lv YJ; Zhang JD; Li YL; Dai QF; Ji Y; Holman RR; Yuan SY;
Diabetes Ther; 2020 Apr; 11(4):885-903. PubMed ID: 32086768
[TBL] [Abstract][Full Text] [Related]
4. Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial.
Soejima H; Ogawa H; Morimoto T; Nakayama M; Okada S; Uemura S; Kanauchi M; Doi N; Sakuma M; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
Circ J; 2012; 76(6):1526-32. PubMed ID: 22447019
[TBL] [Abstract][Full Text] [Related]
5. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes.
Fan D; Li L; Li Z; Zhang Y; Ma X; Wu L; Qin G
Lipids Health Dis; 2018 May; 17(1):102. PubMed ID: 29739462
[TBL] [Abstract][Full Text] [Related]
8. Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: A randomized, open-label trial.
Ueda H; Kido A; Matsuhisa S; Asawa K; Yoshida N; Tsujimoto M; Sasaki Y; Kuga Y; Yamasaki M; Ueda K; Shinohara S; Nishida Y
Am Heart J; 2016 Mar; 173():134-42. PubMed ID: 26920606
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM;
Cerebrovasc Dis; 2009; 27(5):509-18. PubMed ID: 19372653
[TBL] [Abstract][Full Text] [Related]
10. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
Ueki K; Sasako T; Okazaki Y; Kato M; Okahata S; Katsuyama H; Haraguchi M; Morita A; Ohashi K; Hara K; Morise A; Izumi K; Ishizuka N; Ohashi Y; Noda M; Kadowaki T;
Lancet Diabetes Endocrinol; 2017 Dec; 5(12):951-964. PubMed ID: 29079252
[TBL] [Abstract][Full Text] [Related]
11. Report: Impact of drug combination of clopidogrel and pantoprazole In the prognosis of patients with transient ischemic attack.
Lu M
Pak J Pharm Sci; 2017 Jan; 30(1):217-221. PubMed ID: 28603135
[TBL] [Abstract][Full Text] [Related]
12. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
13. Aspirin Resistance Predicts Adverse Cardiovascular Events in Patients with Symptomatic Peripheral Artery Disease.
Pasala T; Hoo JS; Lockhart MK; Waheed R; Sengodan P; Alexander J; Gandhi S
Tex Heart Inst J; 2016 Dec; 43(6):482-487. PubMed ID: 28100965
[TBL] [Abstract][Full Text] [Related]
14. Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial.
Matías-Guiu J; Ferro JM; Alvarez-Sabín J; Torres F; Jiménez MD; Lago A; Melo T;
Stroke; 2003 Apr; 34(4):840-8. PubMed ID: 12649515
[TBL] [Abstract][Full Text] [Related]
15. Triflusal and aspirin in the secondary prevention of atherothrombotic ischemic stroke: a very long-term follow-up.
Alvarez-Sabín J; Quintana M; Santamarina E; Maisterra O
Cerebrovasc Dis; 2014; 37(3):181-7. PubMed ID: 24503927
[TBL] [Abstract][Full Text] [Related]
16. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
[TBL] [Abstract][Full Text] [Related]
17. Pulse pressure and mortality from cerebrovascular diseases in type 2 diabetic patients: the Verona Diabetes Study.
Zoppini G; Verlato G; Zamboni C; Venturi C; Gennaro N; Biasi V; Bonora E; Muggeo M
Cerebrovasc Dis; 2007; 23(1):20-6. PubMed ID: 16968982
[TBL] [Abstract][Full Text] [Related]
18. Lower physical activity is a strong predictor of cardiovascular events in elderly patients with type 2 diabetes mellitus beyond traditional risk factors: the Japanese Elderly Diabetes Intervention Trial.
Iijima K; Iimuro S; Shinozaki T; Ohashi Y; Sakurai T; Umegaki H; Araki A; Ouchi Y; Ito H;
Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():77-87. PubMed ID: 22435943
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of the CHADS
Tabata N; Yamamoto E; Hokimoto S; Yamashita T; Sueta D; Takashio S; Arima Y; Izumiya Y; Kojima S; Kaikita K; Matsui K; Fujimoto K; Sakamoto K; Shimomura H; Tsunoda R; Hirose T; Nakamura N; Sakaino N; Nakamura S; Yamamoto N; Matsumura T; Kajiwara I; Koide S; Sakamoto T; Nakao K; Oshima S; Tsujita K;
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862941
[TBL] [Abstract][Full Text] [Related]
20. Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project.
Milionis H; Ntaios G; Papavasileiou V; Spengos K; Manios E; Elisaf M; Vemmos K
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2769-2777. PubMed ID: 28756905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
